ABSTRACT We performed an in vivo evaluation of bronchodilation using a model of antigen-induced bronchoconstriction in anesthetized guinea pigs pretreated with in domethacin, pyrilamine and propranolol, and the results were compared with those for the histamine-induced response. Test drugs were administered intravenously when the antigen or histamine response reached its peak. Leukotriene (LT) D4 antagonists, FPL55712 and LY171883, gradually reduced the antigen-induced response, whereas the lipoxygenase inhibitor phenidone had no such effect. The bronchodilator theophylline rapidly reduced the antigen-induced response, and the adenylate cyclase activator forskolin had a similar effect. The following drugs also had no effect: nifedi pine (calcium-channel antagonist), cromakalim (potassium-channel opener), amlex anox and disodium cromoglycate: DSCG (anti-allergic drugs), OKY-046 (thrombox ane A2 synthetase inhibitor), and dapsone (anti-inflammatory drug). Theophylline, the beta-adrenoceptor agonist salbutamol and the histamine H1-blocker pyrilamine had only a small reversing effect on histamine-induced bronchoconstriction. These re sults suggest that antigen-, but not histamine-, induced bronchoconstriction in anesthe tized guinea pigs is a useful in vivo model for evaluating the bronchodilating effect of anti-asthmatic drugs.
Bronchodilators, theophylline and beta adrenoceptor agonists are widely used in the therapy of asthma (1, 2) . Theophylline inhibits antigen and agonists-induced bronchospasm in guinea pigs (3, 4) , and it also has an anti allergic effect in rats (5, 6) . Similarly, beta adrenoceptor agonists, salbutamol and iso proterenol, and the adenylate cyclase activator forskolin have anti-asthmatic and anti-allergic activity (7, 8) . Calcium-channel antagonists (9, 10) and potassium channel openers (11) (12) (13) also exhibit bronchodilating effects in the guinea pig, and anti-allergic drugs, DSCG and amlexanox (14) , and the TXA2 synthetase in hibitor OKY-046 (15) inhibit antigen-induced bronchospasm in the guinea pig. However, the bronchodilating effect of these drugs on bron choconstriction in vivo have not been investi gated in detail.
The purpose of the present study was to de velop an in vivo system for examining the bronchodilating effect of anti-asthmatic drugs. Therefore, we examined the reversing effects of anti-asthmatic drugs on antigen-induced bronchoconstriction in anesthetized guinea pigs, because antigen causes slowly developing and sustained bronchoconstriction in sensitized guinea pigs pretreated with indomethacin, 
MATERIALS AND METHODS

Materials
Amlexanox, FPL55712, LY171883, OKY 046 and cromakalim were synthesized in our own laboratory. Dapsone, forskolin, indo methacin, nifedipine, phenidone, propranolol hydrochloride, pyrilamine malate, salbutamol, ovalbumin (OA) and urethane were purchased from Sigma Chemical Co., MO, USA. Theophylline was from Nacalai Tesque, Inc., Japan; and DSCG was from Nihon Bulk, Japan. The rabbit anti-chicken egg albumin serum was from Cooper Biomedical, PA, USA; The 4-hr passive cutaneous anaphylaxis (PCA) titer of this antiserum was 1:4000 in guinea pigs and no 7-day PCA activity was observed, suggesting that this antiserum is IgG-rich. Cromakalim, dapsone, forskolin, in domethacin and nifedipine were dissolved in 100% polyethylene glycol (PEG) 400. FPL55712 was dissolved in 0.3% Tween 80 and LY171883, in 8.4% NaHCO3. Amlexanox was dissolved in I N NaOH and diluted with 0.9% saline. Theophylline was dissolved in phosphate-buffered saline (pH 7.4). The other agents were dissolved in 0.9% saline.
Measurement of air overflow
Male Hartley guinea pigs (300 400 g) were passively sensitized with rabbit anti-chicken egg albumin (0.125 ml/body, i.v.). One day later, the sensitized animals were anesthetized with urethane (1.5 g/kg, i.p.). The right jugu lar vein was cannulated for the i.v.-injection. A tracheal cannula was inserted to permit measurement of air overflow by the modified method described by Konzett and Rossler (16) . Respiration was carried out as follows: 15-20 ml/kg/stroke, 40-50 strokes/min. The increase in respiratory overflow volume pro yoked by OA-challenge or histamine was rep resented as a percentage of the maximal over flow volume (100%) obtained by clamping off the trachea.
Antigen-induced bronchoconstriction
Following surgical preparation, bronchocon striction was induced by intravenously admin istered OA (0.2 mg/kg) in the animals pre treated with indomethacin (2 mg/kg, 10 min), pyrilamine (2 mg/kg, 6 min) and propranolol (0.1 mg/kg, 5 min) before OA challenge (0.2 mg/kg) to eliminate any contribution by en dogenous prostaglandins, histamine and catecholamines.
Histamine-induced bronchoconstriction
Bronchoconstriction was induced by intra venous injection of histamine (10 ,ug/kg).
Reversal of bronchoconstriction
The peak bronchoconstriction induced by antigen or histamine in the approximately 50 70% range was used in these experiments. When the response reached a peak level, drugs or vehicles were administered intra venously and the reversing effect was meas ured for 10 min (OA) or 5 min (histamine). Maximal reversal by anti-asthmatic drugs was calculated as follows: % maximal reversal = [% peak bronchoconstriction before the injec tion of drug or vehicle % bronchoconstric tion at maximal reversal] / [% peak broncho constriction before the injection of drug or vehicle] X 100 Prophylactic effect of drugs on bronchocon striction Drugs were administered intravenously 1 min before antigen challenge. The percent in hibition of drugs was calculated as follows: % Inhibition = [% peak bronchoconstriction of control groups % peak bronchoconstriction of drug-treated groups] / [% peak broncho constriction of control groups] X 100
Statistics
Results are expressed as means ± S.E.M.
Statistical significance (P < 0.05) of the data was evaluated by Student's t-test for unpaired data. 
RESULTS
Antigen-induced bronchoconstriction Intravenous injection of OA into anesthe tized guinea pigs caused slowly developing and sustained bronchoconstriction with a peak re sponse in 5-10 min. LT antagonists, FPL55712 (5 mg/kg) and LY171883 (5 and 10 mg/kg) in travenously administered at the time of the peak response reduced gradually but signifi cantly the antigen-induced response, whereas the lipoxygenase inhibitor phenidone (10 mg/kg), which prevented the antigen-induced response when administered 1 min before OA challenge (Table 2) , had no effect on it ( Fig. 1 and Table 1 ). Theophylline (50 mg/kg) and forskolin (0.1 mg/kg) produced rapid and sig nificant reduction of antigen-induced broncho constriction ( Fig. 2 and Table 3 ). Nifedipine (0.1 mg/kg), cromakalim (1 mg/kg), dapsone (30 mg/kg), DSCG (20 mg/kg), OKY-046 (5 mg/kg) and amlexanox (10 mg/kg) had no effect (Table 4) , while nifedipine, cromakalim, dapsone, amlexanox, but not DSCG, were effective when administered 1 min before OA challenge (Table 2) . 
Histamine-induced bronchoconstriction
Histamine (10,ug/kg) induced a transient bronchoconstriction with a peak at 10 20 sec, which was followed by a decline. Theophylline (50 mg/kg), salbutamol (0.5 mg/kg) and pyri lamine (1 mg/kg) had little reversing effect on the histamine response (Fig. 3) . The dose of pyrilamine used in this experiment completely prevented histamine induced bronchoconstric tion when the animals were treated with the drug before the histamine challenge (data not shown). 
DISCUSSION
Although there is no perfect model for bronchial asthma, animal models are needed to study anti-asthmatic drugs. Guinea pigs have been used in experimental models for asthma, since their airway reactivities to bron choconstrictors and the mediators released in allergic reactions are similar to those found in asthmatic patients (17, 18) . Slow reacting sub stance of anaphylaxis (SRS-A), which consists of peptide-LTs, is an important mediator of pulmonary anaphylaxis in humans and guinea pigs (19) . In sensitized guinea pigs pretreated with indomethacin, pyrilamine and proprano lol, antigen challenge causes slowly developing and sustained bronchoconstriction indicative of a SRS-A response. This response is prevented by LT antagonists and lipoxygenase inhibitors (20, 21 , this paper). In the present study, the LT antagonists FPL55712 and LY171883 gra dually reversed antigen-induced bronchocon striction, but the lipoxygenase inhibitor pheni done, which was prophylactically effective, did not have any significant effect. These results suggest that antigen-induced bronchoconstric tion is already established when it reaches a peak. This interpretation is also supported by our data that the mediator release inhibitor amlexanox, which was prophylactically effec tive and has been reported to exhibit prophyl actic effects on experimental bronchoconstric tion (22) , had no reversing effect on antigen induced bronchoconstriction. In the present study, theophylline and the direct adenylate cyclase activator forskolin rapidly reversed the antigen-induced response. In contrast, the calcium-channel antagonist nifedipine and potassium-channel opener cromakalim, which were prophylactically effective (this paper) and have bronchodilating activity (9 -13), had no effect on it. Though we do not know why nifedipine and cromakalim do not exhibit the reversing effect under our experimental condi tions, this evaluation system is a useful in vivo model for bronchodilation, because theophyl line, which has been widely used in asthmatic patients, produces a rapid reversal of antigen induced bronchoconstriction in anesthetized guinea pigs.
Dapsone has been used as an anti-inflamma tory drug (23) . This compound inhibits the arachidonate lipoxygenase pathway and LTB4 binding (24) . In the present study, dapsone had no reversing effect on the antigen-induced response. In contrast, when given prophylacti cally at the same dose before antigen chal lenge, dapsone significantly protected the animals against antigen-induced bronchocon striction. These observations suggest that the prophylactic effect of dapsone on the antigen induced response involves lipoxygenase inhibi tion, similar to phenidone, indicating that LTB4 may not contribute to the antigen-in duced response.
Histamine, as well as SRS-A, is a very im portant chemical mediator of allergic broncho constriction in both humans and guinea pigs (1). However, airway response induced by en dogenous SRS-A is long-lasting, while that in duced by exogeneous histamine is transient. Antigen-induced histamine-mediated broncho constriction is also known to be transient (25) . In this study, neither theophylline, salbutamol nor the histamine H1 antagonist pyrilamine re versed histamine-induced bronchoconstriction.
The reason for the failure of pyrilamine to antagonize the histamine response is not clear, but may be related to the possibility that the intracellular mechanism of bronchoconstriction induced by exogenously administered hista mine is different from that by endogenously generated SRS-A under these experimental conditions.
In conclusion, we examined the reversing effect of anti-asthmatic drugs on antigen and histamine-induced bronchoconstriction in the guinea pig. The clinically effective broncho dilators used markedly reversed the antigen induced response, but had no effect on the histamine response. These results suggest that the evaluation of reversal by using antigen-in duced bronchoconstriction in the guinea pig is feasible for studying in vivo bronchodilation by anti-asthmatic drugs.
